Regulating SLC7A11/GSH/GPX4 axis by glucose dyshomeostasis to simultaneously promote disulfidptosis, cuproptosis and ferroptosis
As one of the key targets of tumor metabolic therapy, glucose dyshomeostasis by disrupting glucose metabolism possesses the potential to reverse therapeutic resistance of a variety of regulated cell deaths (RCDs), but the functional pathways are not fully revealed and employed. Herein, we demonstrat...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
KeAi Communications Co., Ltd.
2025-12-01
|
| Collection: | Bioactive Materials |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2452199X25004086 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|